Impact of Edge to Edge Transcatheter Tricuspid Valve Repair

Reducing tricuspid regurgitation with transcatheter valve repair is associated to improved liver function, which is often ignored by many cardiologists. This is especially true in cases with deteriorated liver function prior valve repair. Instead, kidney function did not show any changes.

Costo efectividad de la reparación endovascular y quirúrgica en aneurismas complejos

Transcatheter tricuspid valve repair seems attractive especially in patients with liver failure.

Edge to edge tricuspid valve repair emerged an alternative for inoperable patients, or even all patients, since surgical repair is associated with suboptimal results when it comes to repairing or replacing this valve. Always in the shadow of the aortic and mitral valves, tricuspid failure has significant impact on organs long ignored by many cardiologists (for instance the liver).


Read also: Surgery to Improve Survival in Isolated Tricuspid Regurgitation.


The study included 126 patients treated in a transcatheter repair center between 2016 and 2018. Baseline liver and kidney functions were registered and compared against 30-day and 6-month outcomes.

110 patients survived 6 months after procedure. Among them, kidney function remained stable, including that of patients with moderate to severe chronic kidney failure (baseline glomerular filtration 37.5 ml/min/1.73m² vs 40.1 ml/min/1.73m² at 6 months; p=0.39).

As regards liver function, there was significant improvement at 6 months, observed in transaminase and bilirubin levels. The poorer the baseline function, the more it improved.

Conclusion

Reducing tricuspid regurgitation with transcatheter edge to edge repair is associated with significantly improved liver function, while kidney failure remains stable compared to baseline.

This option appears more and more attractive for inoperable patients or even all patients.

Original Title: Impact of Transcatheter Tricuspid Valve Repair for Severe Tricuspid Regurgitation on Kidney and Liver Function.

Reference: Nicole Karam et al. J Am Coll Cardiol Intv 2019. Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...